Auxilium Phramaceuticals (NASDAQ:AUXL)‘s drug to treat Peyronie’s disease, a condition in which the penis is abnormally curved, has achieved positive phase 3 results, according to a company statement. If approved, the Malvern, Pennsylvania company’s drug Xiaflex would be the first biologic to combat the disease. The company said two one-year clinical trials to test safety […]
Auxilium Pharmaceuticals (NASDAQ: AUXL), a specialty pharmaceuticals company, has added two senior executives at the company and announced the departures of three in the latest management shakeup at the company. Andrew I. Koven has been named executive vice president, chief administrative officer and general counsel. Mark A. Glickman has been named senior vice president, sales, […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.